Kezdőlap › Petefészekrák › Washington › Seattle
Petefészekrák klinikai vizsgálatok: Seattle, WA
30 Petefészekrák vizsgálat keres résztvevőket Seattle és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Toborzás folyamatban2. fázis
- Swedish Medical Center-First Hill, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Toborzás folyamatban1/2. fázis
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Toborzás folyamatban
- University of Washington, Seattle
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Toborzás folyamatbanMegfigyeléses tanulmány
- Fred Hutchinson Cancer Center, Seattle
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Toborzás folyamatban1/2. fázis
- Seattle Cancer Care Alliance at South Lake Union - G3630, Seattle
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Toborzás folyamatban3. fázis
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Toborzás folyamatban2. fázis
- Virginia Mason Hospital and Medical Center /ID# 277259, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Toborzás folyamatban1. fázis
- University of Washington Fred Hutchinson, Seattle
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
Toborzás folyamatban2. fázis
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Toborzás folyamatban3. fázis
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Toborzás folyamatban2. fázis
- Swedish Cancer Institute, Seattle
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Toborzás folyamatban
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- és további 3
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Toborzás folyamatban3. fázis
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- és további 4
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Fred Hutchinson Cancer Center, Seattle
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Toborzás folyamatban1/2. fázis
- Swedish Cancer Institute, Seattle
Clinical Pre-screening Protocol for Ovarian Cancer
Toborzás folyamatbanMegfigyeléses tanulmány
- Swedish Center for Research and Innovation, Seattle
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Toborzás folyamatban2/3. fázis
- University of Washington - Seattle Cancer Care Alliance, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Toborzás folyamatban2. fázis
- University of Washington School of Medicine, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Toborzás folyamatban1/2. fázis
- Fred Hutchinson Cancer Center, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Toborzás folyamatban1/2. fázis
- Fred Hutchinson Cancer Center, Seattle
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
Toborzás folyamatbanEgészséges önkéntesek is jelentkezhetnek
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Toborzás folyamatban1/2. fázis
- Fred Hutchinson Cancer Center, Seattle
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Toborzás folyamatban1/2. fázis
- Fred Hutchinson Cancer Center, Seattle
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Toborzás folyamatbanMegfigyeléses tanulmány
- Fred Hutch/University of Washington Cancer Consortium, Seattle
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Toborzás folyamatban
- University of Washington, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Toborzás folyamatban1/2. fázis
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Toborzás folyamatban1. fázis
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Toborzás folyamatbanMegfigyeléses tanulmány
- Massive Bio SYNERGY-AI site, Seattle
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Toborzás folyamatbanMegfigyeléses tanulmány
- The Swedish Hospital, Seattle
Petefészekrák vizsgálatok más városokban
- Houston, TX89 tanulmány
- New York City, NY69 tanulmány
- Boston, MA61 tanulmány
- Los Angeles, CA50 tanulmány
- Nashville, TN49 tanulmány
- Arlington, VA46 tanulmány
- Philadelphia, PA44 tanulmány
- Columbus, OH39 tanulmány
- St. Louis, MO38 tanulmány
- Chicago, IL36 tanulmány
- San Antonio, TX31 tanulmány
- Cleveland, OH30 tanulmány
Egyéb vizsgálatok: Seattle
- Nem kis sejtes tüdőrák53 tanulmány
- Rák (minden típus)49 tanulmány
- Prosztatarák42 tanulmány
- Akut mieloid leukémia41 tanulmány
- Mellrák39 tanulmány
- Áttétes rák39 tanulmány
- Kolorektális rák34 tanulmány
- Tüdőrák33 tanulmány
- Multiplex mielóma22 tanulmány
- Hólyagrák21 tanulmány
- Myelodysplasticus szindrómák21 tanulmány
- Akut limfoblasztos leukémia21 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.